Literature DB >> 11423447

Human papillomavirus in pterygium.

M J Gallagher1, A Giannoudis, C S Herrington, P Hiscott.   

Abstract

AIM: To determine the prevalence and significance of human papillomaviral types in conjunctival pterygia.
METHODS: Polymerase chain reaction technology was used to identify the presence of human papillomavirus (HPV) in 10 formalin fixed paraffin embedded pterygia samples. 10 conjunctival papillomas were used as positive controls. 20 conjunctival samples, 10 with primary acquired melanosis and 10 with malignant melanoma, were used as negative controls. Sample subgroups were of equal sex, race, and age distribution to eliminate bias. All samples were further analysed (for 21 HPV types) using dot-blot hybridisation techniques.
RESULTS: HPV was identified in 90% of the conjunctival papillomas, 50% of the pterygia samples, but no HPV was detected in the negative control group. Two pterygia showed type 6, two type 11, and one type 16. These three HPV types were also detected in papillomas.
CONCLUSION: These results suggest that HPV may be involved in the pathogenesis of pterygia and that broadly the same HPV types are found in pterygia and in papillomas. Persistent conjunctival HPV may possibly play a part in the recurrence of pterygia post excision but further larger studies are required to elucidate this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423447      PMCID: PMC1724030          DOI: 10.1136/bjo.85.7.782

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium.

Authors:  D T Tan; W Y Tang; Y P Liu; H S Goh; D R Smith
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes.

Authors:  P J McDonnell; J M McDonnell; T Kessis; W R Green; K V Shah
Journal:  Hum Pathol       Date:  1987-11       Impact factor: 3.466

Review 3.  Human papillomaviruses and their possible role in squamous cell carcinomas.

Authors:  H zur Hausen
Journal:  Curr Top Microbiol Immunol       Date:  1977       Impact factor: 4.291

4.  A hypothesis on the pathogenesis of pterygiums.

Authors:  W W Wong
Journal:  Ann Ophthalmol       Date:  1978-03

Review 5.  Pterygium as an early indicator of ultraviolet insolation: a hypothesis.

Authors:  M T Coroneo
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

6.  Pterygium excision with conjunctival autografting: an effective and safe technique.

Authors:  B D Allan; P Short; G J Crawford; G D Barrett; I J Constable
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

7.  Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi.

Authors:  K M Waddell; S Lewallen; S B Lucas; C Atenyi-Agaba; C S Herrington; G Liomba
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

8.  Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia.

Authors:  J M McDonnell; P J McDonnell; Y Y Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-01       Impact factor: 4.799

Review 9.  Molecular events in uterine cervical cancer.

Authors:  S A Southern; C S Herrington
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

10.  Basal keratinocyte tetrasomy in low-grade squamous intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specific.

Authors:  A Giannoudis; M F Evans; S A Southern; C S Herrington
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more
  22 in total

1.  Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.

Authors:  Angel Nava-Castañeda; Isabel Ulloa-Orozco; Lilia Garnica-Hayashi; Joaquín Hernandez-Orgaz; Maria Carmen Jimenez-Martinez; Yonathan Garfias
Journal:  J Ocul Pharmacol Ther       Date:  2014-11-04       Impact factor: 2.671

2.  Does human papillomavirus cause pterygium?

Authors:  T W Reid; N Dushku
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

3.  Detection of human papillomavirus DNA in pterygia from different geographical regions.

Authors:  F Piras; P S Moore; J Ugalde; M T Perra; A Scarpa; P Sirigu
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

4.  Lack of human papillomavirus in pterygium of Chinese patients from Taiwan.

Authors:  K-H Chen; W-M Hsu; C-C Cheng; Y-S Li
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

5.  New approach for pterygium removal using 20 % ethanol.

Authors:  Erez Tsumi; Jaime Levy; Anry Pitchkhadze; Amjad Baidousi; Tova Lifshitz
Journal:  Int Ophthalmol       Date:  2012-06-21       Impact factor: 2.031

6.  The risk of pterygium in salt workers.

Authors:  Murli L Mathur; Kripa Ram Haldiya; Raman Sachdev; Habibulla N Saiyed
Journal:  Int Ophthalmol       Date:  2006-06-16       Impact factor: 2.031

7.  Human papillomavirus and pterygium. Is the virus a risk factor?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Jan Ulrik Prause; Bodil Norrild; Troels Vinding; Steffen Heegaard
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

8.  Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation.

Authors:  Nick Di Girolamo; Minas Coroneo; Denis Wakefield
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

9.  Risk factors for conjunctival squamous cell neoplasia: a matched case-control study.

Authors:  W Tulvatana; P Bhattarakosol; L Sansopha; W Sipiyarak; E Kowitdamrong; T Paisuntornsug; S Karnsawai
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

10.  Human papillomavirus infection and squamous cell carcinoma of the conjunctiva.

Authors:  C Ateenyi-Agaba; S Franceschi; F Wabwire-Mangen; A Arslan; E Othieno; J Binta-Kahwa; L-J van Doorn; B Kleter; W Quint; E Weiderpass
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.